Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Biochimie|August 13, 2013
Ceramide and the mitochondrial respiratory chainAviram Kogot-Levin, Ann Saada
Plos One|October 26, 2016
Upregulation of Mitochondrial Content in Cytochrome c Oxidase Deficient FibroblastsAviram Kogot-Levin, Ann Saada, Gil Leibowitz, et al.
Endocrine-Related Cancer|June 27, 2015
Development of pheochromocytoma in ceramide synthase 2 null miceWoo-Jae Park, Ori Brenner, Aviram Kogot-Levin, et al.
Reproductive Toxicology (Elmsford, N.Y.)|September 4, 2018
The influence of in vivo exposure to nonylphenol ethoxylate 10 (NP-10) on the ovarian reserve in a mouse modelYoel Shufaro, Ann Saada, Monica Simeonov, et al.
The FEBS Journal|February 25, 2021
Pathogenesis of diabesity-induced kidney disease: role of kidney nutrient sensingLiad Hinden, Aviram Kogot-Levin, Joseph Tam, et al.
Pediatric Research|February 28, 2009
Mucolipidosis type IV: the effect of increased lysosomal pH on the abnormal lysosomal storageAviram Kogot-Levin, Marsha Zeigler, Asher Ornoy, et al.
Biochemical Society Transactions|December 2, 2010
Mucolipidosis type IV and the mucolipinsGideon Bach, David A Zeevi, Ayala Frumkin, et al.
The Journal of Biological Chemistry|January 4, 2013
Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chainHila Zigdon, Aviram Kogot-Levin, Joo-Won Park, et al.
The Journal of Pathology|June 27, 2009
A potentially dynamic lysosomal role for the endogenous TRPML proteinsDavid A Zeevi, Ayala Frumkin, Vered Offen-Glasner, et al.
The Journal of Biological Chemistry|September 11, 2013
Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalizationWoo-Jae Park, Joo-Won Park, Racheli Erez-Roman, et al.
Pageof 16